Shanghai Fudan Forward S&T Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fudan Forward S&T Co Ltd with three other
companies in this sector in China:
Zhejiang Starry Pharmaceutical Co Ltd
sales of 672.75 million Chinese Renmimbi [US$101.70 million]
of which 99%
was Pharmaceuticals Industry),
Coland Holdings Limited
(675.24 million Chinese Renmimbi [US$102.08 million]
of which 100%
was Medical Services), and
Ginwa Enterprise Group Inc.
(666.08 million Chinese Renmimbi [US$100.69 million]
of which 73%
was Pharmaceutical Industry).
During the year ended December of 2016, sales at
Shanghai Fudan Forward S&T Co Ltd were 670.57 million Chinese Renmimbi (US$101.37 million).
decrease of 6.3%
versus 2015, when the company's sales were 715.69 million Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Shanghai Fudan Forward S&T Co Ltd had sales
of 725.11 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 11.3% decline
in Industrial, from 422.85 million Chinese Renmimbi to 375.09 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Software Development (up 12.6% to 259.75 million Chinese Renmimbi)
Other Operations (up 193.6% to 36.40 million Chinese Renmimbi)